Steven Clayton to Female
This is a "connection" page, showing publications Steven Clayton has written about Female.
Connection Strength
0.293
-
Horton AJ, Clayton SB. Optimization of impedance-measured reflux events in GORD utilizing acid exposure time. BMC Gastroenterol. 2020 Jun 09; 20(1):179.
Score: 0.051
-
Clayton S, Cauble E, Kumar A, Patil N, Ledford D, Kolliputi N, Lopes-Virella MF, Castell D, Richter J. Plasma levels of TNF-a, IL-6, IFN-?, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD). BMC Gastroenterol. 2019 Feb 11; 19(1):28.
Score: 0.046
-
Clayton S, DeClue C, Lewis T, Rodriguez A, Kolkhorst K, Syed R, Kumar A, Davis C, Brady P. Radiologic versus Endoscopic Placement of Gastrostomy Tube: Comparison of Indications and Outcomes at a Tertiary Referral Center. South Med J. 2019 01; 112(1):39-44.
Score: 0.046
-
Clayton SB, Shin CM, Ewing A, Blonski W, Richter J. Pneumatic dilation improves esophageal emptying and symptoms in patients with idiopathic esophago-gastric junction outflow obstruction. Neurogastroenterol Motil. 2019 03; 31(3):e13522.
Score: 0.046
-
Clayton SB, Patel R, Richter JE. Functional and Anatomic Esophagogastic Junction Outflow Obstruction: Manometry, Timed Barium Esophagram Findings, and Treatment Outcomes. Clin Gastroenterol Hepatol. 2016 06; 14(6):907-911.
Score: 0.038
-
Clayton SB, Castell DO. Multiple good options are available for achalasia management. J Clin Gastroenterol. 2015 Mar; 49(3):194-8.
Score: 0.035
-
Rodriguez AC, Clayton S, Brady P, Mamel J. Images of the Month: A Rare Cause of Overt Gastrointestinal Bleeding. Am J Gastroenterol. 2016 Feb; 111(2):171.
Score: 0.009
-
Patel R, Clayton S, Quintero E, Gill J. Chronic Opioid Users Are More Difficult to Sedate than Alcoholics and Controls. South Med J. 2015 Dec; 108(12):744-7.
Score: 0.009
-
Singh ER, Rife C, Clayton S, Naas P, Nietert P, Castell DO. Interobserver variability in esophageal body measurements with high-resolution manometry among new physician users. J Clin Gastroenterol. 2013 Feb; 47(2):e12-6.
Score: 0.008
-
Rizzieri DA, Akabani G, Zalutsky MR, Coleman RE, Metzler SD, Bowsher JE, Toaso B, Anderson E, Lagoo A, Clayton S, Pegram CN, Moore JO, Gockerman JP, DeCastro C, Gasparetto C, Chao NJ, Bigner DD. Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma. Blood. 2004 Aug 01; 104(3):642-8.
Score: 0.004